文献速递男科与性医学前列腺癌膀胱癌与上尿路尿路上皮癌

真实世界背景下的血精:一种新的高风险分层

Haemospermia in the Real- Life Setting: A New High-Risk Stratification.
PubMed 文献 · Urology · 2022-10-12

回顾性分析283例单次或复发性血精患者,按EAU指南分层并验证其诊断效能,同时基于与精液培养阳性及前列腺癌、膀胱癌相关的临床因素构建新风险分层模型。EAU指南的敏感性、特异性、AUC分别为13.3%、89.2%、51%,新模型分别为98.9%、58%、78%。

要点

  • EAU指南将91.5%(259/283)血精患者归为高风险,仅8.5%(24/283)为低风险。
  • 复发性泌尿生殖道感染史是精液培养阳性的预测因素(OR 3.39,95%CI 1.77-6.57,P=.002)。
  • 基线CCI≥1是前列腺癌和膀胱癌的预测因素(OR 1.55,95%CI 1.17-2.04,P=.009)。

核心结论

  • 应用EAU指南风险分层不能确保恰当识别主诉血精的高风险患者,作者提出一种性能更好且易于实施的新风险分层工具。

研究设计与样本

  • 回顾性分析283例连续主诉单次或复发性血精的患者,按EAU指南分为低风险与高风险并验证其诊断性能,同时基于与精液培养阳性及前列腺癌、膀胱癌相关的临床因素构建新风险分层模型,比较两种模型的诊断准确性和决策曲线分析。

主要发现

  • 按EAU指南,259例(91.5%)为高风险,24例(8.5%)为低风险。
  • 134例(47.4%)报告复发性血精,126例(44.5%)基线CCI评分≥1。
  • 多变量logistic回归分析中,复发性泌尿生殖道感染史是精液培养阳性的预测因素(OR 3.39,95%CI 1.77-6.57,P=.002)。
  • 基线CCI≥1是前列腺癌和膀胱癌的预测因素(OR 1.55,95%CI 1.17-2.04,P=.009)。
  • EAU指南的敏感性、特异性、AUC分别为13.3%、89.2%、51%,新模型分别为98.9%、58%、78%。

关键数值与推荐

  • EAU指南分层:高风险259例(91.5%),低风险24例(8.5%)。
  • 复发性泌尿生殖道感染史预测精液培养阳性:OR 3.39(95%CI 1.77-6.57,P=.002)。
  • 基线CCI≥1预测前列腺癌和膀胱癌:OR 1.55(95%CI 1.17-2.04,P=.009)。
  • EAU指南诊断性能:敏感性13.3%,特异性89.2%,AUC 51%。
  • 新模型诊断性能:敏感性98.9%,特异性58%,AUC 78%。

临床怎么用

  • 原文结论认为EAU指南风险分层不能确保恰当识别主诉血精的高风险患者,作者提出一种新的风险分层工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To (i) identify a novel risk stratification for patients complaining of haemospermia; and, (ii) compare its predictive ability to select high-risk patients by retrospectively validating the EAU guidelines classification. METHODS: Data from 283 consecutive patients complaining of a single episode/recurrent haemospermia were retrospectively analyzed. Patients were stratified into low vs high-risk according to EAU guidelines, whose diagnostic performance was then validated. We identified a new risk stratification model based on clinical factors associated with (i) positive semen culture and (ii) prostate cancer (PCa) and bladder cancer (BC). Diagnostic accuracy of the two predictive models (EAU vs New) was assessed and decision curve analyses (DCA) tested their clinical benefit. RESULTS: Overall, 259 (91.5%) were high-risk and 24 (8.5%) low risk according to the EAU guidelines. Recurrent haemospermia was reported by 134 (47.4%) patients. 126 (44.5%) had baseline CCI score ≥ 1. At MVA logistic regression analysis, history of recurrent genito - urinary tract infections was identified as a predictor for positive semen culture (OR: 3.39, 95% CI: 1.77 - 6.57, P =.002). Likewise, baseline CCI ≥ 1 was identified as a predictor for PCa and BC (OR: 1.55, 95% CI: 1.17 - 2.04, P =.009). Sensitivity, specificity, and AUC of the EAU guidelines were 13.3%, 89.2% and 51% respectively, whereas the new model performed substantially better: 98.9%, 58% and 78% respectively. CONCLUSION: The application of the EAU guidelines risk stratification does not ensure proper identification of high-risk patients complaining of haemospermia. We propose a novel, better performing and easily implementable risk stratification tool.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Pozzi E, Ventimiglia E, Fallara G, et al. Haemospermia in the Real- Life Setting: A New High-Risk Stratification. Urology. 2022. PMID: 36241064. doi:10.1016/j.urology.2022.09.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。